Good evening :)
Place Order
Add to Watchlist

Unichem Laboratories Ltd

UNICHEMLAB Share Price

589.300.44% (-2.60)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

UNICHEMLAB Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

UNICHEMLAB Performance & Key Metrics

UNICHEMLAB Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
28.801.76
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.346.560.83%

UNICHEMLAB Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

UNICHEMLAB Company Profile

Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives).

UNICHEMLAB Similar Stocks (Peers)

Compare with peers Compare with peers 

UNICHEMLAB Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
37.05
37.05
1Y Return
11.30%
11.30%
Buy Reco %
87.88
87.88
PE Ratio
23.02
23.02
1Y Return
1.45%
1.45%
Buy Reco %
74.19
74.19
PE Ratio
59.18
59.18
1Y Return
20.55%
20.55%
Buy Reco %
76.00
76.00
PE Ratio
19.14
19.14
1Y Return
4.32%
4.32%
Buy Reco %
55.17
55.17
PE Ratio
21.83
21.83
1Y Return
7.11%
7.11%
Buy Reco %
46.43
46.43
Compare with Peers

UNICHEMLAB Forecast

UNICHEMLAB Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

UNICHEMLAB

UNICHEMLAB

Income

Balance Sheet

Cash Flow

UNICHEMLAB Income Statement

UNICHEMLAB Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 7.1%, vs industry avg of 9.02%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.58% to 0.47%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue882.813,553.471,280.291,195.841,285.331,317.341,381.541,804.502,146.292,109.48
Raw Materialssubtract262.42387.73477.13422.92467.52457.36533.73743.721,846.111,805.86
Power & Fuel Costsubtract41.6249.2376.3973.0268.8978.05102.84107.14
Employee Costsubtract169.04200.64238.52273.28306.97330.49356.41393.06
Selling & Administrative Expensessubtract233.92291.18420.94345.54316.35287.13299.84361.41
Operating & Other expensessubtract32.1017.9350.5639.77-15.3645.07134.33124.94
Depreciation/Amortizationsubtract43.5250.5167.3781.6784.3691.17113.44113.24124.56120.82
Interest & Other Itemssubtract3.368.017.527.855.126.1117.3122.6621.0321.03
Taxes & Other Itemssubtract-11.853.34-34.3511.9717.15-11.0925.868.8017.0717.08
EPS11.96315.72-3.38-8.554.884.69-28.72-10.0119.5320.55
DPS3.005.004.004.004.004.004.000.000.000.00
Payout ratio0.250.020.820.850.000.000.00

UNICHEMLAB Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF

Investor Presentation

Jun 9PDF
Feb 6PDF
Nov 4PDF
Aug 16PDF
FY 2016FY 2016

Annual report

PDF

Investor Presentation

Jun 1PDF
Feb 4PDF
FY 2015FY 2015

Annual report

PDF
 

UNICHEMLAB Stock Peers

UNICHEMLAB Past Performance & Peer Comparison

UNICHEMLAB Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Unichem Laboratories Ltd30.301.76
Sun Pharmaceutical Industries Ltd37.056.030.95%
Cipla Ltd23.023.881.06%
Torrent Pharmaceuticals Ltd59.1816.490.96%

UNICHEMLAB Stock Price Comparison

Compare UNICHEMLAB with any stock or ETF
Compare UNICHEMLAB with any stock or ETF
UNICHEMLAB
Loading...

UNICHEMLAB Holdings

UNICHEMLAB Shareholdings

UNICHEMLAB Promoter Holdings Trend

UNICHEMLAB Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

UNICHEMLAB Institutional Holdings Trend

UNICHEMLAB Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

UNICHEMLAB Shareholding Pattern

UNICHEMLAB Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding70.22%9.89%1.43%0.98%17.48%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

UNICHEMLAB Shareholding History

UNICHEMLAB Shareholding History

Dec '23MarJunSepDec '24Mar0.84%0.90%0.89%0.94%1.06%0.98%

Mutual Funds Invested in UNICHEMLAB

Mutual Funds Invested in UNICHEMLAB

No mutual funds holding trends are available

Top 5 Mutual Funds holding Unichem Laboratories Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
7.8564%0.96%-0.22%44/89 (-9)
1.2231%1.72%-0.01%19/34 (0)
0.3460%0.26%-0.08%46/47 (0)

Compare 3-month MF holding change on Screener

UNICHEMLAB Insider Trades & Bulk Stock Deals

UNICHEMLAB Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing UNICHEMLAB stock

smallcases containing UNICHEMLAB stock

Looks like this stock is not in any smallcase yet.

UNICHEMLAB Events

UNICHEMLAB Events

UNICHEMLAB Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

UNICHEMLAB Dividend Trend

No dividend trend available

UNICHEMLAB Upcoming Dividends

UNICHEMLAB Upcoming Dividends

No upcoming dividends are available

UNICHEMLAB Past Dividends

UNICHEMLAB Past Dividends

Cash Dividend

Ex DateEx DateAug 1, 2022

Final
Final | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Aug 1, 2022

Cash Dividend

Ex DateEx DateJul 22, 2021

Final
Final | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Jul 22, 2021

Cash Dividend

Ex DateEx DateAug 20, 2020

Final
Final | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Aug 20, 2020

Cash Dividend

Ex DateEx DateJul 18, 2019

Final
Final | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Jul 18, 2019

Cash Dividend

Ex DateEx DateJul 19, 2018

Final
Final | Div/Share: ₹5.00

Dividend/Share

5.00

Ex DateEx Date

Jul 19, 2018

UNICHEMLAB Stock News & Opinions

UNICHEMLAB Stock News & Opinions

Spotlight
Unichem Labs slides after receiving three USFDA observations at Roha facility

In a regulatory filing, the company stated that the USFDA conducted the inspection from 16 June to 20 June 2025. At the conclusion of the inspection, the USFDA issued three observations, which were primarily related to procedural changes, with none related to data integrity. The company stated that it will provide the necessary response to the USFDA within the stipulated 15-day period. The official announcement was made on Saturday, 21 June 2025. Unichem Laboratories is engaged in the manufacturing of pharmaceutical products. The company reported a consolidated net profit of Rs 52.97 crore in Q4 FY25, compared with a net loss of Rs 129.31 crore in Q4 FY24. Revenue from operations jumped 36% year-on-year to Rs 587.18 crore in Q4 FY25. Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Unichem Laboratories to convene AGM

Unichem Laboratories announced that the 62th Annual General Meeting(AGM) of the company will be held on 4 August 2025.Powered by Capital Market - Live

1 week agoCapital Market - Live
Earnings
Unichem Laboratories reports consolidated net profit of Rs 52.97 crore in the March 2025 quarter

Net profit of Unichem Laboratories reported to Rs 52.97 crore in the quarter ended March 2025 as against net loss of Rs 129.31 crore during the previous quarter ended March 2024. Sales rose 36.02% to Rs 587.18 crore in the quarter ended March 2025 as against Rs 431.70 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 137.52 crore in the year ended March 2025 as against net loss of Rs 93.76 crore during the previous year ended March 2024. Sales rose 18.25% to Rs 2110.97 crore in the year ended March 2025 as against Rs 1785.11 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales587.18431.70 36 2110.971785.11 18 OPM %14.255.87 -12.554.87 - PBDT87.4926.91 225 279.1595.81 191 PBT57.80-0.25 LP 154.59-27.35 LP NP52.97-129.31 LP 137.52-93.76 LP Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Unichem Laboratories to table results

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 22 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Unichem Laboratories receives update in credit ratings from ICRA

Unichem Laboratories announced that t ICRA, the credit rating agency has upgraded the rating to [ICRA] A+ from [ICRA] A assigned earlier to the Rs. 180.0 crore bank facilities of the Company. Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Unichem Laboratories consolidated net profit declines 20.99% in the December 2024 quarter

Net profit of Unichem Laboratories declined 20.99% to Rs 57.85 crore in the quarter ended December 2024 as against Rs 73.22 crore during the previous quarter ended December 2023. Sales rose 14.47% to Rs 533.09 crore in the quarter ended December 2024 as against Rs 465.72 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales533.09465.72 14 OPM %16.046.68 - PBDT92.3936.81 151 PBT61.855.19 1092 NP57.8573.22 -21 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Unichem Laboratories schedules board meeting

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Unichem Laboratories reports consolidated net profit of Rs 30.49 crore in the September 2024 quarter

Net profit of Unichem Laboratories reported to Rs 30.49 crore in the quarter ended September 2024 as against net loss of Rs 24.49 crore during the previous quarter ended September 2023. Sales rose 11.20% to Rs 462.16 crore in the quarter ended September 2024 as against Rs 415.63 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales462.16415.63 11 OPM %12.452.11 - PBDT61.537.57 713 PBT32.99-21.88 LP NP30.49-24.49 LP Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Unichem Laboratories to discuss results

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Unichem Laboratories to hold board meeting

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 30 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Unichem Laboratories Ltd (UNICHEMLAB) today?

    The share price of UNICHEMLAB as on 30th June 2025 is ₹589.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Unichem Laboratories Ltd (UNICHEMLAB) share?

    The past returns of Unichem Laboratories Ltd (UNICHEMLAB) share are
    • Past 1 week: 2.39%
    • Past 1 month: -1.95%
    • Past 3 months: -15.44%
    • Past 6 months: -16.61%
    • Past 1 year: 11.05%
    • Past 3 years: 144.93%
    • Past 5 years: 236.55%

  3. What are the peers or stocks similar to Unichem Laboratories Ltd (UNICHEMLAB)?
  4. What is the market cap of Unichem Laboratories Ltd (UNICHEMLAB) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Unichem Laboratories Ltd (UNICHEMLAB) is ₹4167.32 Cr as of 30th June 2025.

  5. What is the 52 week high and low of Unichem Laboratories Ltd (UNICHEMLAB) share?

    The 52-week high of Unichem Laboratories Ltd (UNICHEMLAB) is ₹937.95 and the 52-week low is ₹511.55.

  6. What is the PE and PB ratio of Unichem Laboratories Ltd (UNICHEMLAB) stock?

    The P/E (price-to-earnings) ratio of Unichem Laboratories Ltd (UNICHEMLAB) is 30.30. The P/B (price-to-book) ratio is 1.76.

  7. Which sector does Unichem Laboratories Ltd (UNICHEMLAB) belong to?

    Unichem Laboratories Ltd (UNICHEMLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Unichem Laboratories Ltd (UNICHEMLAB) shares?

    You can directly buy Unichem Laboratories Ltd (UNICHEMLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.